Liminatus Pharma LIMN
NASDAQ LIMN
$3.91 -0.36 (-8.43%)
At close: Sep 29, 2026 · 4:00 PM EDT

Liminatus Pharma (LIMN) Research & Development (2024 - 2026)

Updated

Liminatus Pharma (LIMN) recorded Research & Development of $600,000 in Q2 2026, up 50.0% from the prior quarter.

Analysis

Liminatus Pharma (LIMN) Research & Development (2024 - 2026) Analysis & Trends

On a TTM basis, Liminatus Pharma's Research & Development came in at $1 million as of Jun 30, 2026, up 180.1% year-over-year; for FY2024, it came in at $2.69 million.

  • The Q2 2026 figure is the highest quarterly Research & Development since Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 3.65 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 2.34 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -4.05 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 1.76 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 993.80 Mn
10 Liminatus Pharma 4.78 Mn 4.78 Mn - 600,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 600,000.00
Mar 31, 2026 400,000.00
Sep 30, 2024 357,066.00
Jun 30, 2024 714,134.00
API Access

Liminatus Pharma Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=LIMN&period=max&api_key=YOUR_API_KEY